Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155632 · ClinicalTrials.gov registry record · Phase 2
Neurocircuit Strategy to Decrease Cocaine Cue Reactivity
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT04155632 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 32 participants.
The verdict
NCT04155632, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
The overarching goal of this project is to examine the effect of combining theta burst stimulation (TBS) and N-acetylcysteine (NAC) on cocaine craving and brain response to cocaine-related images.
Interventions
- DRUG N-acetylcysteine
- DEVICE Theta-burst stimulation (TBS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2023-03-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155632
The ClinicalTrials.gov registry entry for NCT04155632 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which N-acetylcysteine is the first listed.
NCT04155632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04155632 about?
NCT04155632 is a clinical study titled "Neurocircuit Strategy to Decrease Cocaine Cue Reactivity". The overarching goal of this project is to examine the effect of combining theta burst stimulation (TBS) and N-acetylcysteine (NAC) on cocaine craving and brain response to cocaine-related images.
What is the current status of trial NCT04155632?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2020-12-18. Estimated completion is 2023-03-09.
What interventions are being tested in trial NCT04155632?
The interventions under investigation include: N-acetylcysteine (DRUG), Theta-burst stimulation (TBS) (DEVICE).
Who is sponsoring clinical trial NCT04155632?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.